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Using the human WERI-Rb1 cell line as a model system, we performed a genome-wide search for retinal target genes of thyroid hor-
mone (TH) via expression microarray analysis followed by quantitative real-time RT-PCR veriﬁcation. We identiﬁed 12 novel retinal
targets of TH, including 10 up-regulated genes (OPN1MW, OPN1LW, TIMP3, RP1L1, GNGT2, CRX, ARR3, GCAP1, IMPDH1,
and PDE6C) and 2 down-regulated genes (GNGT1 and GNB3). In addition, we found a number of novel TH-targets that are not cur-
rently known to be retinal genes. This is the ﬁrst report of human retinal targets regulated by thyroid hormone.
Published by Elsevier Ltd.
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Thyroid hormone (TH) action is known to direct the
development and function of many tissues, especially the
brain, liver and heart (reviewed in Viguerie & Langin,
2003; Yen, 2001). Recent studies in mice have revealed that
TH and its b2 receptor (TRb2) also play a pivotal role in
retinal development. A dorsal-ventral gradient of TH is
established in developing mouse retina around post-natal
day 10, correlating with the spatial and temporal distribu-
tion of the middle-wave-sensitive (M) cone opsin expres-
sion (Roberts, Srinivas, Forrest, Morreale de Escobar, &
Reh, 2006). In addition, TRb2 expression is restricted to
cone photoreceptors in mouse retina (Roberts, Hendrick-
son, McGuire, & Reh, 2005) and more importantly, dele-
tion of the gene encoding for TRb2 in mice results in
complete loss of M cones (Ng et al., 2001). These results0042-6989/$ - see front matter Published by Elsevier Ltd.
doi:10.1016/j.visres.2007.04.023
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E-mail address: ywliu@u.washington.edu (Y. Liu).indicate that TH action is essential for M cone develop-
ment and diﬀerentiation, possibly via regulation of M cone
opsin expression, as well as other cone-speciﬁc genes.
Diﬀerent from rodents, which are dichromatic with only
M and S (short-wave-sensitive) cones, humans are trichro-
matic with L (long-wave-sensitive), M, and S (short-wave-
sensitive) cones in the retina. The human L and M cone
opsin genes (OPN1LW and OPN1MW, respectively) are
located on the X chromosome and are arranged in a
head-to-tail tandem array (reviewed in Deeb, 2004). These
two opsins are highly homologous with only 15 out of 364
amino acids being diﬀerent. In fact, the L-opsin gene is
derived from the M-opsin gene via a duplication event that
occurred during evolution and includes both the coding
and promoter regions. Furthermore, a regulatory sequence
upstream of the L-opsin gene, called the locus control
region (LCR), can control the expression of both L- and
M-opsin genes (Wang et al., 1992). Interestingly, while
these two genes have almost identical promoter sequence,
their expression in human retina is mutually exclusive.
Despite all that is known about these genes, the mechanism
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largely unknown.
Several lines of evidence suggest that the role of TH and
its receptor in mouse retina is similar in the human system.
In 1977, a case report from Germany showed that a dele-
tion in the human TRb gene in a patient was associated
with S cone monochromacy, indicating that both the L
and M cones were missing (Newell & Diddie, 1977). In
addition, transgenic mice bearing a reporter construct dri-
ven by the upstream regulatory sequence of the human
L/M locus showed a similar expression pattern to that seen
with the endogenous mouse M-opsin (Fei & Hughes, 2001;
Wang et al., 1992). These data strongly support the
hypothesis that expression of both human L and M cone
opsins is regulated by TH and its receptors during retinal
development.
To test whether thyroid hormone regulates the tran-
scription of human L- and M-opsin genes, we took advan-
tage of a human retinoblastoma cell line WERI-Rb1
(hereafter referred as WERI). WERI is an early stage cone
lineage cell line, expressing low levels of L- and M-opsin
(Shaaban & Deeb, 1998). Previously, we had found that
these cells express L- and M-opsin in a mutually exclusive
pattern, similar to the human retina and the choice of
expressing L- or M-opsin can be reset during cell division
(Deeb, Liu, & Hayashi, 2006). In this paper, we showed
that WERI cells are also ideal for investigation of TH
action on human retinal genes. Using WERI as a model
system we determined by expression microarray and quan-
titative real-time RT-PCR (qRT-PCR) analyses that the
L- and M-opsin genes are transcriptional targets of thyroid
hormone. In addition, a number of other novel TH-targets
were also identiﬁed.
2. Methods
2.1. Cell culture
The human retinoblastoma cell line WERI-Rb1 (WERI) was obtained
from the American Type Culture Collection and maintained as a suspen-
sion culture in RPMI 1640 supplemented with L-glutamine and 10% fetal
bovine serum (Hyclone). For experiments with thyroid hormone treat-
ment, WERI cells were shifted 2 or 3 days before the treatment to medium
with 2% B27, a deﬁned serum-free substitute (Invitrogen) instead of fetal
bovine serum. The triiodothyronine (T3) stock solution was prepared in
1 N NaOH at a concentration of 100 lM. All-trans retinoic acid (ATRA)
and 9-cis retinoic acid stock solutions were prepared in DMSO at a 10 mM
concentration. All chemicals were obtained from Sigma.
2.2. RNA extraction, RT-PCR and qRT-PCR
Total RNA was extracted from WERI cells using either the Versagene
RNA extraction kit (Gentra Systems) or Trizol reagent (Invitrogen) and
reverse transcribed (RT) using iScript cDNA synthesis kit (Bio-Rad) in
a 10 or 20 ll reaction. cDNA samples from the RT reactions were used
as templates for PCR ampliﬁcation using LA-Taq polymerase (TAKA-
RA). The sequence of the isoform-speciﬁc primers for human TRa1,
TRa2, TRb1 and TRb2 are given in Malo et al. (2004). Primer sequences
for PCR gel analysis and SYBR Green-based quantitative PCR (qPCR)
are listed in Table 1. Taqman-based qPCR assays were purchased from
Applied Biosystems (ABI) and are listed as follows: APOE(Hs00171168_m1), ARR3 (Hs00182888_m1), CRX (Hs00230899_m1),
CRYM (Hs00157121_m1), CST11 (Hs00370023_m1), DELGEF
(Hs00183730_m1), DPP4 (Hs00175210_m1), GAPDH (Hs99999905_m1),
GNB3 (Hs00157740_m1), GNGT1 (Hs00184207_m1), GNGT2 (Hs002
58864_m1), GCAP1 (Hs00181172_m1), HEG1 (Hs00419997_m1), HR
(Hs00218222_m1), IMPDH1 (Hs00265302_m1), LIPG (Hs00195812_m1),
LMOD1 (Hs00201704_m1), OPN1LW/OPN1MW (Hs00241039_m1),
PDE6C (Hs00196421_m1), PDE6H (Hs00196432_m1), PYY (Hs003738
90_g1), RP1L1 (Hs00698865_m1), RRAD (Hs00188163_m1), SAG (Hs0
0167021_m1), SALL1 (Hs00231307_m1), TIMP3 (Hs00165949_m1).
All qPCR analyses were performed using the Applied Biosystems 7500
apparatus and analyzed by the Relative Quantiﬁcation ddCt method.
SYBR Green-based qPCRs were performed using Power SYBR Green
Master Mix (ABI). Taqman probe-based qPCRs were performed using
Taqman Universal Master Mix (ABI). The cycling parameters for
SYBR-qPCR analysis are listed in Table 1 with an additional dissociation
step to monitor the speciﬁcities of ampliﬁed products. For Taqman-qPCR,
we use the default cycling conditions (40 cycles of 95 C 15 s and 60 C
1 min).2.3. Microarray analysis
WERI cells were treated in triplicates for 48 h with either 100 nM T3
or solvent (0.001 N NaOH) and harvested for RNA extraction. The array
experiment was performed by the Center of Expression Arrays at the Uni-
versity of Washington (http://expression.washington.edu/). Brieﬂy, each
sample with 5 lg RNA was reverse transcribed, biotin-labeled by
in vitro transcription, and then hybridized to human whole genome
U133 plus 2.0 oligonucleotide chips (Aﬀymetrix) following the Aﬀymetrix
recommended procedures. The chips were stained with streptavidin-phy-
coerythrin and scanned using the GeneChip Scanner (Aﬀymetrix). The
data ﬁles were then analyzed by ArrayAssist software (Stratagene) and
lists of diﬀerentially expressed genes (fold-changeP 2, p-value 6 .05 or
fold-changeP 4, p-value 6 .01) were generated using the PLIER probe
level analysis algorithm (Aﬀymatrix) and two-sample Student’s t-test.
Selected target genes identiﬁed by microarray were veriﬁed by Taqman-
based qRT-PCR assays as described above.3. Results
3.1. WERI cell line as a model system to examine T3 action
on human retinal genes
To date, no studies of human retinal genes regulated by
T3 have been reported, most likely due to the limitation on
available human retinal tissues. An alternative approach is
to use cell lines for such a study. Human WERI retinoblas-
toma cells have been shown to express the thyroid hormone
receptors (TR) and many retinal-speciﬁc genes (Li, Zhu,
Brown, & Craft, 2003). Since TRs include diﬀerent iso-
forms and form heterodimers with members of the retinoid
X receptor (RXR) family to mediate T3 action, we ﬁrst
examined which isoforms of TR and RXR are present in
WERI cells. RT-PCR analysis was performed using iso-
form-speciﬁc primers (Malo et al., 2004). As shown in
Fig. 1, WERI cells express all four TR isoforms: TRa1,
TRa2, TRb1 and TRb2, with TRb2 being at the highest
concentration. Interestingly, we found that the TRb1
PCR product was smaller (about 350 bp) than previously
reported (484 bp) (Malo et al., 2004). Sequence analysis
of this smaller TRb1 product indicated that it matches
the TRb1 sequence, but is missing exons 2 and 3 for a total
Table 1
Primers used for RT-PCR and SYBR-based qRT-PCR analyses
Methods Gene symbol Primer Sequence (5 0–30) Cycling condition
Gel analysis GAPDH GAPDH1F CGCTGAGTACGTCGTGGAGTC 95 C 15 s and 64 C 50 s (25 cycles)
GAPDH1R CACAGTCTTCTGGGTGGCAGT
RXRA hRXRa-F CAT CTT TGA CAG GGT GCT GAC 95 C 15 s, 62 C 30 s, 72 C 40 s (35 cycles)
hRXRa-R TGC TCT GGG TAC TTG TGC TTG
RXRB hRXRb-F GAG TAG GAG CCA TCT TTG ATC G
hRXRb-R TAG CAG CAG CTT GGC AAA CCG
RXRG hRXRc-F GGT CGG CTC CAT CTT TGA CAG
hRXRc-R TTG GCA AAC CTG CCT GGC TG
L/M-opsin CB196 TACCCCGGGGTGCAGTCTTAC 98 C 10 s and 66 C 30 s (30 cycles)
CB78 TTGGCAGCAGCAAAGCATGCG
SYBR-qPCR M-opsin (OPN1MW) CB7G ACCCCACTCAGCATCATCGT 95 C 15 s and 62 C 40 s (40 cycles)
CB79G CCAGCAGAAGCAGAATGCCAGGAC
L-opsin (OPN1LW) CB7R ATCCCACTCGCTATCATCAT
CB79R CCAGCAGACGCAGTACGCAAAGATC
GMPR GMPR-F1 CGTGTTCAGCTAACCCTGGGGAC 95 C 15 s and 65 C 40 s (40 cycles)
GMPR-R1 ACCATTCAGGAGCAGCCAGAAGC
ITM2C ITM2C-F1 AAGCAAGGAGCTAGGACCCCCAG
ITM2C-R1 GACTGAGCAGTGACCTTGCCTGC
KIAA1755 KIAA1755-F1 TCATTGTGGAAAGACCTGTCGGC
KIAA1755-R1 ACCCGAGGGGAGAGCTGTGTATG
MARCO MARCO-F1 GGGACAATTTGCGATGACGAGTG
MARCO-R1 CCAGCTCCCACTTTGTACAGGGC
PAMLM2-AKAP2 PALM2-AKAP2-F1 TGCATTCTGCCGTGTTTATAGGTG
PALM2-AKAP2-R1 TGCCACTGACAGACCCTGTTTCC
RARI14 RAI14-F1 ACGCTTGCAACTTCCCTTATGGC
RAI14-R1 ACTGAGGCCAAGCAGCCTTGTG
SPON2 SPON2-F1 CTGCTCTCAGCCTCCTCCTCCTG
SPON2-R1 CCCCTGGACGATGAAGGACAATC
TFF1 TFF1-F1 TCGACGTCCCTCCAGAAGAGGAG
TFF1-R1 GCAGAAGCGTGTCTGAGGTGTCC
THEDC1 THEDC1-F1 GTACATTCAAAGGCCTGGCATCG
THEDC1-R1 CTTCAGCAAAATGCTTGGGGGTG
TP53I3 TP53I3-F1 AGGCAAGATCGTCCTGGAACTGC
TP53I3-R1 TAAACGGCTCTGGAGGAAGCACC
TRA@ TRA@-F1 CTCGAACCGAACAGCAGTGCTTC
TRA@-R1 TCTCTCAGCTGGTACACGGCAGG
TU3A TU3A-F1 TGGTGTGAGGACCATGCTGTGAG
TU3A-R1 GTTGCAGAAGTGGGGTGGGAATC
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Fig. 1. WERI cells express high levels of TRb2 and RXRc. RNA
extracted from WERI cells was used to perform RT-PCR analysis using
isoform-speciﬁc primers as described in Table 1. The predicted product
size for TRa1 = 346 bp, TRa2 = 467 bp, TRb1 = 484 bp, TRb2 = 307 bp,
RXRa = 201 bp, RXRb = 239 bp, RXRc = 228 bp. * = TRb1 PCR prod-
uct size is smaller than predicted (484 bp). See text for explanation.
2316 Y. Liu et al. / Vision Research 47 (2007) 2314–2326loss of 136 nucleotides. In addition, WERI cells express all
three RXR isoforms. RXRc is expressed at the highest
level among the RXR isoforms (Fig. 1). These results sug-
gest that TRb2/RXRc heterodimers are likely the predom-inant form of thyroid hormone receptor complexes in
WERI cells.
Expression of the L/M-opsin mRNA has been shown to
be up-regulated by retinoic acid in WERI cells (Li et al.,
2003). We tested whether its expression is also regulated
by T3. RNA extracted from WERI cells treated with either
T3 or retinoic acid (ATRA or 9-cis RA) were used to
perform RT-PCR analysis to compare the expression of
L/M-opsin mRNA with that of COUPTF1, a known
RA-responsive gene (Li et al., 2003). We need to point
out here that due to the high homology between the
L- and M-opsin genes, many studies do not distinguish
between these two genes. In this paper, we consider the
L- and M-opsin genes as one unit when the assay ampliﬁes
the mRNA of both genes (shown as L/M, or OPN1LW/
OPN1MW), but as two units when the assay speciﬁcally
ampliﬁes the mRNA of either L- or M-opsin gene. As
shown in Fig. 2, the L/M-opsin mRNA was dramatically
Mock T39-c RAATRA
GAPDH
(25 cyc)
COUPTF1
(35 cyc)
L/M opsin 
(30 cyc)
Fig. 2. T3 induces the transcription of the L/M-opsin gene in WERI cells.
WERI cells were either treated with vehicle (mock), 10 lM all-trans
retinoic acid (ATRA), 10 lM 9-cis retinoic acid (9c-RA), or 10 nM T3
(T3) for 48 h. RNA extracted from these samples was used to perform RT-
PCR analyses using primer pairs that amplify the L/M-opsin gene (top
panel), COUPTF1 (middle panel), or the housekeeping gene GAPDH
(bottom panel).
Y. Liu et al. / Vision Research 47 (2007) 2314–2326 2317induced by T3 (10 nM) in WERI cells, but only weakly
activated by ATRA or 9-cis RA (Fig. 2, top panel). In
contrast, the expression level of COUPTF1 was highly
induced by ATRA or 9-cis RA, but not by T3 (Fig. 2, mid-
dle panel). On the other hand, the house keeping gene,
GAPDH, was expressed at similar levels among all the
samples (Fig. 2, bottom panel). These results indicate that
WERI cells are T3-responsive and suitable for identiﬁca-
tion of retinal targets of thyroid hormone.ig. 3. Microarray expression proﬁle of WERI cells treated with T3. (a)
catter plot of hybridization signals of RNA fromWERI cells treated with
00 nM T3 (TH, Y-axis) versus signals from a mock treated sample
mock). Up-regulated transcripts are indicated by red + sign; down-
egulated transcripts are indicated by green + sign; yellow + sign indicate
ranscripts with similar expression levels in the TH and mock samples. (b)
catter plot of p-values (Y-axis) versus fold-change (X-axis, log2 scale).
he red + sign on the bottom left are transcripts down-regulated by 4-fold
r more with p-value of 6.01; red + signs on the bottom right represent
ranscripts that are up-regulated by 4-fold or more with p-values of 6.01.
c) Heatmap of probe sets on ±4-fold, p 6 .01 list generated by cluster
nalysis. Note the three biological replicates show similar levels of
expression.3.2. Identiﬁcation of TH-targets in WERI cells by expression
microarray analysis
To systematically identify target genes of TH in WERI
cells, we performed a genome-wide search using expression
microarray analysis. To ensure robust signals, we chose to
treat WERI cells with 100 nM T3. Although this dose is
much higher than physiological concentration (around
1 nM), no toxic eﬀects on WERI cells were observed. The
Aﬀymetrix U133+2.0 chip used for the microarray analysis
contains approximately 54 K probe sets representing about
38,000 genes, including all known retinal-speciﬁc genes.
Three biological replicates were used for statistical analysis.
After 48 h of T3 treatment, WERI cells were harvested for
RNA extraction. The quality of the RNA samples was
tested by an Agilent Bioanalyzer. Induction of L/M-opsin
in T3 treated samples was examined by RT-PCR analysis
to assure that the T3 treatment worked well (data not
shown). Six samples of RNA (3 mock treated, 3 treated
with 100 nM T3) were then labeled and hybridized to
U133+2.0 chips. The raw data generated were analyzed
by the ArrayAssist software (Stratagene) using the PLIER
algorithm for probe level analysis and a two-sample Stu-
dent’s t-test for the determination of statistically signiﬁcant
changes in mRNA concentrations. As shown in Fig. 3a and
c, T3 treatment induces a global gene expression proﬁleF
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three biological replicates. From a total of 54,675 probe
sets (some genes contain multiple probe sets on the chip)
tested, we found that 534 probe sets showed up-regulation
of 2-fold or more (p-value 6 .05) and 479 probe sets
showed down-regulation of 2-fold or more (p-value 6 .05).
A total of 97 probe sets, representing 69 genes, were
induced 4-fold or more with a p-value of 6.01 (Fig. 3b,
Table 2), and 61 probe sets, representing 50 genes, were
down-regulated 4-fold or more with a p-value of 6.01
(Fig. 3b, Table 3). The complete list of diﬀerentially
expressed genes with P2-fold, p-value 6 .05 can be found
in Supplementary Material.
Not surprisingly, we found that the induction level of
the L/M-opsin gene (OPN1LW/OPN1MW) was the high-
est (44.68-fold) on the list of up-regulated genes (Table
2). In addition to the L/M-opsin gene, the following four
retinal genes were induced more than 4-fold (p 6 .01):
CRX (cone rod homeobox), a homeodomain-containing
transcription factor that is essential for the development
of cone and rod photoreceptors; TIMP3 (tissue inhibitor
of metalloproteinases), the gene that is mutated in Sorsby’s
fundus dystrophy, a retinal degenerative disease; GNGT2
(the c subunit of cone-speciﬁc transducin), and RP1L1
(RP1-like protein 1), a gene with sequence similarity to
RP1 (retinitis pigmentosa 1). The term retinal gene here
is deﬁned as a gene found on the lists of retinal disease
genes in the RetNet database (www.sph.uth.tmc.edu/Ret-
net) and retina enriched genes derived from EST, SAGE
and microarray data (Qian et al., 2005).
Thyroid hormone receptors can also function as tran-
scriptional repressors in a ligand-dependent or independent
manner (reviewed in Yen, 2001). There are a number of ret-
inal candidates that could potentially be regulated by thy-
roid hormone negatively: the S-opsin, which was found to
be inhibited by thyroid hormone in mouse models and
in vitro reporter analysis (Roberts et al., 2006; Yanagi,
Takezawa, & Kato, 2002); NRL and NR2E3, two rod-spe-
ciﬁc transcription factors which positively regulate rod cell
diﬀerentiation and rod-speciﬁc gene expression but have
negative impact on the cone pathway (Chen, Rattner, &
Nathans, 2005; Cheng et al., 2006; Oh et al., 2007). How-
ever, although the U133+2.0 chip contains probes for these
genes, no signiﬁcant change in mRNA levels in response to
T3 were observed by microarray analysis. Instead, GNGT1
(the c subunit of rod-speciﬁc transducin) was the only ret-
inal gene found to be down-regulated by more than 4-fold
(19.90-fold). We suspect that some negative targets of
thyroid hormone could be missed using the WERI model
system since the cells were most likely derived from a pre-
cursor cell that was committed to the L/M cone lineage.
Unexpectedly, we found that most diﬀerentially
expressed genes identiﬁed (Tables 2 and 3) have not previ-
ously been reported to be expressed in the retina and to be
TH-responsive. Only one gene on our 4-fold induced list,
the hairless gene (HR), has been previously reported to
be responsive to TH (Thompson, 1996).3.3. Veriﬁcation of microarray data by qRT-PCR
The success of detecting induction of the L/M-opsin
gene by microarray analysis indicates that the array hybrid-
ization experiments were well executed. However, to get a
better sense of the performance of the microarray data,
we decided to verify additional genes on our list. Since
we only found six retinal genes (OPN1LW and OPN1MW
are counted as one unit here) on the 4-fold (p-value 6 .01)
list, we decide to expand our search to retinal genes found
on the 2-fold list (p-value 6 .05). We identiﬁed a total of 13
retinal genes from the 2-fold (p-value 6 .05) list, including
six previously identiﬁed from the 4-fold list (Table 4).
Quantitative real-time RT-PCR conﬁrmed the microarray
results in 12 out of 13 retinal genes tested (Table 4. and
Fig. 4). Change in expression of SAG, the rod arrestin
gene, was the only false positive retinal gene found. This
gene was identiﬁed as a weakly induced gene by microarray
analysis (2.24-fold), but showed no signiﬁcant change by
qRT-PCR analysis. The fold inductions measured by
qRT-PCR were generally higher than those obtained from
microarray analysis. This is a common phenomenon for
microarray experiments due to the saturation of array
hybridization signals.
We also examined by qRT-PCR analysis a subset of the
non-retinal genes identiﬁed by expression microarray anal-
ysis. Similar to what was found with the retinal genes, 23
out of 24 non-retinal genes were conﬁrmed by qRT-PCR
(Table 4). The T cell receptor a (TRA@) was found to be
the only false positive. Although TRA@ was found to be
highly induced (10.81-fold) by microarray analysis, it was
not detectable in the presence or absence of T3 by qRT-
PCR analysis.
In summary, we veriﬁed by qRT-PCR a total of 35 out
of 37 T3-responsive genes identiﬁed by microarray analy-
sis, which is 94.6%. These results indicate that our expres-
sion microarray experiment was well performed and the
data are reliable.
3.4. The identiﬁed retinal targets are regulated by TH at
physiological concentration
Since the microarray experiment was performed using
100 nM T3, which is much higher than the physiological
concentration (about 1 nM), we wanted to conﬁrm that
the target genes identiﬁed would also be regulated at phys-
iological concentrations. To address this question, we per-
formed a dose–response experiment on all the retinal target
genes identiﬁed. WERI cells were treated for 48 h with dif-
ferent doses of T3 (1, 10 and 100 nM), as indicated in
Fig. 5, and the expression of each gene was measured by
qRT-PCR. As expected, the induction of L/M-opsin
mRNA was substantial. Even at 1 nM T3 concentration,
L/M-opsin mRNA level increased more than 200-fold
compared to the untreated samples. To determine the eﬀect
of T3 on L-opsin versus M-opsin expression, we developed
a qRT-PCR assay using L-speciﬁc or M-speciﬁc primers.
Table 2
T3-induced genes in WERI cells (fold-changeP 4, p-value 6 .01)
Rank Gene symbol UniGene ID Gene name Fold
1 OPN1MW Hs.247787 Cone opsin, medium-wave-sensitive 44.68
OPN1LW Hs.592247 Cone opsin, long-wave-sensitive
2 LMOD1*** Hs.519075 Leiomodin 1 (smooth muscle) 24.46
3 PALM2-AKAP2 Hs.591908 PALM2-AKAP2 protein 12.75
4 KIAA1755 Hs.472690 KIAA1755 protein 12.33
5 Unknown Hs.26039 Homo sapiens, clone IMAGE:3869276, 12.00
6 DPP4** Hs.368912 Dipeptidylpeptidase 4 (CD26, adenosine deaminase complexing protein 2) 10.68
7 CST11 Hs.128100 Cystatin 11 10.60
8 TRA@** Hs.74647 T cell receptor alpha locus 9.85
9 TP53I3 Hs.50649 Tumor protein p53 inducible protein 3 9.64
10 TU3A Hs.506357 TU3A protein 9.15
11 RAI14 Hs.431400 Retinoic acid induced 14 8.93
12 MARCO Hs.67726 Macrophage receptor with collagenous structure 8.83
13 THEDC1 Hs.24309 Thioesterase domain containing 1 8.68
14 ITM2C Hs.111577 Integral membrane protein 2C 8.19
15 PYY Hs.169249 Peptide YY 8.06
16 SPON2 Hs.302963 Spondin 2, extracellular matrix protein 7.94
17 TFF1 Hs.162807 Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) 7.77
18 GMPR Hs.484741 Guanosine monophosphate reductase 7.69
19 RRAD** Hs.1027 Ras-related associated with diabetes 7.57
20 TMEM35 Hs.45140 Transmembrane protein 35 7.50
21 HR Hs.272367 Hairless homolog (mouse) 7.49
22 FNDC5 Hs.524234 Fibronectin type III domain containing 5 7.24
23 MAP2 Hs.368281 Microtubule-associated protein 2 6.90
24 PSCD1 Hs.191215 Pleckstrin homology, Sec7 and coiled-coil domains 1 (cytohesin 1) 6.84
25 FHOD3 Hs.436636 Formin homology 2 domain containing 3 6.77
26 RUTBC2 Hs.474397 RUN and TBC1 domain containing 2 6.75
27 JUP Hs.514174 Junction plakoglobin 6.67
28 HEG*** Hs.477420 HEG homolog 1 (zebraﬁsh) 6.57
29 TXNIP*** Hs.533977 Thioredoxin interacting protein 6.45
30 Unknown Hs.436603 Transcribed locus 6.39
31 APOE*** Hs.110675 Apolipoprotein E 6.06
32 CD52** Hs.276770 CD52 antigen (CAMPATH-1 antigen) 6.06
33 SALL1** Hs.135787 Sal-like 1 (Drosophila) 6.05
34 MONDOA** Hs.437153 Mlx interactor 5.99
35 TNC Hs.143250 Tenascin C (hexabrachion) 5.76
36 Unknown Hs.533721 Hypothetical protein KIAA0284 5.73
37 ABCC4 Hs.508423 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 5.64
38 RAB37 Hs.351413 RAB37, member RAS oncogene family 5.61
39 Unknown Hs.7413 Transcribed locus 5.60
40 JARID2*** Hs.269059 Jumonji, AT rich interactive domain 2 5.57
41 CRX Hs.617342 Cone–rod homeobox 5.52
42 TIMP3**** Hs.297324 Tissue inhibitor of metalloproteinase 3 5.51
43 DPYSL3** Hs.519659 Dihydropyrimidinase-like 3 5.50
44 GLUL*** Hs.518525 Glutamate-ammonia ligase (glutamine synthase) 5.50
45 GAS6*** Hs.369201 Growth arrest-speciﬁc 6 5.38
46 KIAA1622 Hs.259599 KIAA1622 5.19
47 ATP1B1 Hs.291196 ATPase, Na+/K+ transporting, b1 polypeptide 5.17
48 P4HA2 Hs.519568 Procollagen-proline, 2-oxoglutarate 4-dioxygenase 5.15
49 Cep164 Hs.504009 KIAA1052 protein 5.05
50 GNGT2 Hs.181781 G protein, gamma transducing activity polypeptide 2 5.00
51 EPHX2 Hs.212088 Epoxide hydrolase 2, cytoplasmic 4.98
52 LDLRAD3 Hs.205865 Low density lipoprotein receptor 4.86
53 SOX7 Hs.213194 SRY (sex determining region Y)-box 7 4.65
54 FGFR1 Hs.264887 Fibroblast growth factor receptor 1 4.58
55 SLC9A3R1 Hs.396783 Solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulator 1 4.56
56 ANKRD33 Hs.433492 Ankyrin repeat domain 33 4.50
57 C19orf30 Hs.326728 Chromosome 19 open reading frame 30 4.49
58 Unknown Hs.446662 Transcribed locus, strongly similar to NP_057175.1 4.46
59 RP1L1 Hs.33538 Retinitis pigmentosa 1-like 1 4.43
60 PSG9** Hs.502092 Pregnancy speciﬁc b-1-glycoprotein 9 4.40
61 LOXL1 Hs.65436 Lysyl oxidase-like 1 4.40
62 ELA3A** Hs.181289 Elastase 3A, pancreatic (protease E) 4.31
(continued on next page)
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Table 2 (continued)
Rank Gene symbol UniGene ID Gene name Fold
63 SCN1B Hs.436646 Sodium channel, voltage-gated, type I, b 4.25
64 PITPNC1 Hs.591185 Phosphatidylinositol transfer protein, cytoplasmic 1 4.22
65 SLC2A3** Hs.419240 Solute carrier family 2, member 3 4.21
SLC2A14 Solute carrier family 2, member 14
66 LIPG Hs.465102 Lipase, endothelial 4.16
67 CCL26 Hs.131342 Chemokine (C-C motif) ligand 26 4.11
68 OLFM1 Hs.522484 Olfactomedin 1 4.01
69 HIPK2 Hs.397465 Homeodomain interacting protein kinase 2 4.00
Note:Gene symbols with bold font are retinal genes. Gene symbols with asterisks indicate that the fold induction is the average of multiple probe sets from
the array, **, 2 probe sets; ***, 3 probe sets;****, 4 probe sets.
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T3, although at 1 nM T3 the induction of M-opsin mRNA
level (350-fold) was more dramatic than that of the L-opsin
mRNA level (40-fold). TIMP3, another gene dramatically
induced by T3, was up-regulated more than 15-fold by
1 nM T3 (Fig. 5b). The induction of the other eight retinal
targets was below 10-fold (Fig. 5c), but nevertheless
showed a good dose–response. Most importantly, except
for PDE6H, all these genes showed a signiﬁcant induction
(p-value 6 .05) at 1 nM T3 compared with the untreated
group (No T3). On the other hand, the two down-regulated
genes showed no dose-dependency of the T3 repression
(Fig. 5d). Treatment with 1 nM T3 resulted in similar levels
of reduction as that seen with 100 nM T3 treatment. This
indicates that T3-dependent repression is very sensitive
and saturated at doses higher than 1 nM. We conclude
from this dose–response experiment that PDE6H is not sta-
tistically signiﬁcantly aﬀected by T3 treatment at physio-
logical concentration but the other 12 retinal TH-targets
(OPN1LW and OPN1MW are counted as two genes here)
identiﬁed by microarray are physiologically relevant.
Next, we decided to measure the kinetics of the
T3-response of above retinal genes. In general, the induc-
tion of a target gene that is directly activated by thyroid
hormone receptor should be faster than a gene that is indi-
rectly activated via an intermediate transcription factor.
Therefore, the kinetics may give us some clues about the
mechanism of induction. A time course experiment was
performed using 5 nM T3 at various time points (0, 6H,
24H, and 48H) as indicated in Fig. 6. A 5 nM T3 dose
was chosen because it can generate robust signals and is
close to the physiological concentration. Based on the
kinetics, we categorized the up-regulated genes into three
groups, fast (F,P3-fold induction at 6H time point), med-
ium (M,P3-fold induction at 24H time point) and slow (S,
<3-fold at both 6H and 24H time points). As shown in
Fig. 6a, the activation of the L- and M-opsin genes by
T3 was not only potent, but also very fast. After just 6 h,
the induction reached its maximal level and remained at
similar levels at both 24 and 48 h treatments. TIMP3,
CRX, GNGT2 and IMPDH1 also fell into the F group that
was induced more than 3-fold only after 6 h T3 treatment.
ARR3, GCAP1, PDE6C and RP1L1 fell into the M group
which reached 3-fold inductions at 24 h time point. Onlyone gene (PDE6H) fell into the S group. Signiﬁcant induc-
tion of PDE6H was not observed until the 48H time point.
Combining this result with the insigniﬁcant induction by
1 nM T3, we concluded that the eﬀect of T3 on PDE6H
is most likely an in vitro artifact due to the high T3 dose
and probably not important in vivo. Therefore, we removed
PDE6H from our ﬁnal list of retinal targets of thyroid
hormone.
While most induced target genes reached their maxi-
mal expression level by the 6H or 24H time points, max-
imal repression of GNGT1 and GNB3 by T3 was not
observed until the 48H time point (Fig. 6d). This is prob-
ably due to the time it takes to degrade the mRNA of
these genes in the cells. Nevertheless, we believe that
the inhibition took eﬀect immediately after T3 treatment,
which is supported by the quick decrease of expression at
6H. Such an inhibition could be mediated by two diﬀer-
ent mechanisms, binding of TR to a negative responsive
element in these genes and recruitment of transcriptional
co-repressor(s) or titrating away transcriptional co-fac-
tor(s) that are required for activation of these genes.
Further work will be required to elucidate the actual
mechanism of the T3-dependent inhibition of GNGT1
and GNB3.
4. Discussion
4.1. Transcriptional regulation of OPN1LW and OPN1MW
opsin genes by thyroid hormone
Using expression microarray and quantitative RT-PCR
analysis, we showed in this paper that the expression of
both human L- and M-opsin genes (OPN1LW and
OPN1MW) was rapidly and highly induced by T3 in
WERI cells. This result is consistent with the in vivo data
showing thyroid hormone and its receptor TRb2 are
required for M cone development in mice (Ng et al.,
2001; Roberts et al., 2006), and strongly suggests that the
L- and M-opsin genes are direct transcriptional targets of
T3. However, the cis-regulatory element responsible for
the T3-response of the L/M locus has not been identiﬁed
yet. Yanagi et al. reported that the locus control region
(LCR) contributes to the T3-response of the L/M-opsin
gene (Yanagi et al., 2002). They found that T3 (at 1 lM)
Table 3
T3-repressed genes in WERI cells (fold-change 6 4, p-value 6 .01)
Rank Gene symbol UniGene ID Gene title Fold
1 GNGT1 Hs.642688 G protein, gamma transducing activity polypeptide 1 19.90
2 Unknown Hs.56400 Similar to Cdc42 guanine nucleotide exchange factor zizimin 1 13.47
3 LOC387763 Hs.530443 Hypothetical LOC387763 12.82
4 SGPP2** Hs.210043 Sphingosine-1-phosphate phosphotase 2 11.00
5 SLIT3 Hs.145601 Slit homolog 3 (Drosophila) 9.83
6 LHX4 Hs.496545 LIM homeobox 4 9.40
7 NAP5 Hs.516471 Nck-associated protein 5 8.94
8 LOC440934 Hs.238964 Hypothetical gene supported by BC008048 8.63
9 PCSK2 Hs.315186 Proprotein convertase subtilisin/kexin type 2 8.25
10 NDRG4 Hs.322430 NDRG family member 4 7.89
11 LOC440928 Hs.528187 Hypothetical gene supported by AK096649 7.23
12 SLC27A6 Hs.49765 Solute carrier family 27 (fatty acid transporter), member 6 6.96
13 EBF3 Hs.205433 Early B-cell factor 3 6.66
14 ABCC8 Hs.54470 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 6.58
15 Unknown Hs.554010 Transcribed locus 6.11
16 FLJ34870 Hs.270083 FLJ34870 protein 5.87
17 FOXP2*** Hs.282787 Forkhead box P2 5.80
18 ADRA2A Hs.249159 Adrenergic, alpha-2A-, receptor 5.79
19 DDIT4L Hs.480378 DNA-damage-inducible transcript 4-like 5.72
20 MFAP4 Hs.296049 Microﬁbrillar-associated protein 4 5.54
21 CNTN1** Hs.143434 Contactin 1 5.53
22 HHIP Hs.507991 Hedgehog interacting protein 5.39
23 PRDM1*** Hs.436023 PR domain containing 1, with ZNF domain 5.35
24 PDZK1 Hs.444751 PDZ domain containing 1 5.32
25 Unknown Hs.147881 Homo sapiens, clone IMAGE:4826545, mRNA 5.30
26 ADCY2** Hs.481545 Adenylate cyclase 2 (brain) 5.27
27 PTPRG Hs.148340 Protein tyrosine phosphatase, receptor type, G 5.19
28 KIAA1913 Hs.172870 KIAA1913 5.03
29 LOC643771 Hs.549665 Hypothetical protein LOC643771 5.03
30 Unknown Hs.356481 CDNA clone IMAGE:4077090, partial cds 4.85
31 Unknown Hs.146050 Transcribed locus 4.81
32 SV2C*** Hs.482549 Synaptic vesicle glycoprotein 2C 4.80
33 ISOC1 Hs.483296 Isochorismatase domain containing 1 4.79
34 APCDD1 Hs.293274 Adenomatosis polyposis coli down-regulated 1 4.78
35 GSG1 Hs.558558 Germ cell associated 1 4.70
36 CTNND2** Hs.314543 Catenin (cadherin-associated protein), delta 2 4.63
37 UNC93A Hs.145911 Unc-93 homolog A (C. elegans) 4.58
38 RPL10A Hs.148340 Ribosomal protein L10a 4.49
39 ERN1 Hs.133982 Endoplasmic reticulum to nucleus signalling 1 4.41
40 Unknown Hs.552087 CDNA clone IMAGE:5922621, partial cds 4.37
41 SPAG1 Hs.492373 Sperm associated antigen 1 4.36
42 HT017 Hs.558524 HT017 protein 4.34
43 DOC1 Hs.104672 Down-regulated in ovarian cancer 1 4.29
44 NSE2 Hs.124951 Breast cancer membrane protein 101 4.27
45 C10orf13 Hs.466120 Chromosome 10 open reading frame 13 4.26
46 AMPD3 Hs.501890 Adenosine monophosphate deaminase (isoform E) 4.23
47 BAI3 Hs.13261 Brain-speciﬁc angiogenesis inhibitor 3 4.18
48 PRG-3 Hs.382683 Plasticity related gene 3 4.17
49 CAP2 Hs.132902 CAP, adenylate cyclase-associated protein, 2 (yeast) 4.04
50 LGI2 Hs.12488 Leucine-rich repeat LGI family, member 2 4.02
Note:Gene symbols with asterisks indicate that the fold induction is the average of multiple probe sets from the array, **, 2 probe sets; ***, 3 probe
sets.
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transfected with a reporter construct containing the LCR
region of the human L/M locus (fused with a thymidine
kinase promoter) and a TRb2 expression vector. This weak
induction is inconsistent with the substantial induction
(P500-fold by 100 nM T3 treatment) of the endogenous
L/M-opsin genes observed after T3 treatment. Further-
more, the LCR does not contain a consensus thyroid hor-mone responsive element (TRE). We analyzed a 10 kb
segment upstream of the L/M locus using Alibaba software
(http://www.gene-regulation.com/pub/programs/alibaba2)
and found a number of potential TREs. Two sites match
the consensus DR4 structure of a TRE (direct repeat of
two half-site AGGTCA separated by four nucleotides),
while others contain only a single half-site, which may also
function in transcriptional activation by tethering a second
Table 4
Validation of microarray data by qRT-PCR analysis
Gene function Gene symbol UniGene Hs. No. Microarray Real-time Validation
Fold p-value Fold p-value
Retinal genes Cone phototransduction OPN1MW/ 247787 44.68 6.01 546.64 6.01 True
OPN1LW 592247
GNGT2 181781 5.00 6.01 4.37 6.01 True
ARR3 308 2.93 6.01 3.10 6.01 True
GCAP1** 92858 2.70 6.01 3.00 6.01 True
PDE6H 54471 2.21 6.01 2.22 6.01 True
PDE6C 93173 2.06 6.05 2.64 6.01 True
GNB3 534315 2.41 6.05 2.85 6.01 True
Rod phototransduction SAG 32721 2.24 6.05 1.00 .99 False
GNGT1 642688 19.90 6.01 21.74 6.05 True
Transcription CRX 617342 5.52 6.01 4.22 6.01 True
Others TIMP3**** 297324 5.51 6.01 10.74 6.01 True
RP1L1 33538 4.43 6.01 9.17 6.01 True
IMPDH1 534808 2.85 6.01 2.90 6.01 True
Non-retinal genes Auditory function SALL1 135787 6.05 6.01 8.08 6.01 True
DELGEF 32470 2.61 6.01 3.01 6.01 True
CRYM 924 2.59 6.05 3.02 6.01 True
Cardiac function HEG*** 477420 6.57 6.01 6.91 6.01 True
APOE*** 110675 6.06 6.01 7.46 6.01 True
Gene regulation HR 272367 7.49 6.01 90.05 6.01 True
Immune response TRA@ 74647 10.81 6.01 Not detectable False
MARCO 67726 8.83 6.01 103.47 6.01 True
Metabolism LMOD1*** 519075 24.46 6.01 235.44 6.01 True
DPP4** 368912 10.68 6.01 80.05 6.01 True
CST11 128100 10.60 6.01 40.28 6.01 True
PYY 169249 8.06 6.01 54.93 6.01 True
GMPR 484741 7.69 6.01 33.12 6.01 True
RRAD** 1027 7.57 6.01 11.37 6.01 True
LIPG 465102 4.16 6.01 7.10 6.01 True
Others PALM2/AKAP2 259461 12.75 6.01 125.19 6.01 True
KIAA1755 472690 12.33 6.01 238.97 6.01 True
THEDC1 24309 10.23 6.05 58.24 6.01 True
TP53I3 50649 9.64 6.01 14.72 6.01 True
TU3A 8022 9.15 6.01 28.85 6.01 True
RARI14 431400 8.93 6.01 15.33 6.01 True
ITM2C 111577 8.19 6.01 16.37 6.05 True
SPON2 302963 7.94 6.01 12.99 6.01 True
TFF1 162807 7.77 6.01 24.71 6.01 True
Note: Gene symbols with asterisks indicate that the fold induction is the average of multiple probe sets from the array, **, 2 probe sets; ***, 3 probe sets;
****, 4 probe sets.
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chromatin immunoprecipitation (ChIP) and reporter anal-
ysis to identify the regulatory sequences that are responsi-
ble for induction of the L- and M-opsin genes by T3.
4.2. Other retinal genes regulated by thyroid hormone
We identiﬁed a total of 12 retinal genes whose expres-
sion is regulated by thyroid hormone. Among them, eight
genes are involved in phototransduction signaling. Seven
are in the cone pathway (OPN1MW, OPN1LW, ARR3,
GCAP1, GNGT2, PDE6C, and GNB3) and one is in the
rod pathway (GNGT1). Interestingly, genes involved in
the cone pathway are mostly induced except for GNB3,
which is weakly down-regulated. On the other hand, the
only gene involved in the rod pathway, GNGT1, the rod-
speciﬁc gamma subunit of transducin, is the most highlyrepressed gene. What is worth pointing out is that GNGT2,
the counterpart of GNGT1 in the cone, is signiﬁcantly up-
regulated by thyroid hormone. These results suggest that
thyroid hormone may direct cone photoreceptor develop-
ment and diﬀerentiation through both positive regulation
of cone-speciﬁc genes and negative regulation of rod-spe-
ciﬁc genes.
CRX, the cone–rod homeobox gene, is the only tran-
scription factor identiﬁed among the retinal targets.
CRX is known to be essential for the development and
function of both cone and rod photoreceptors (Freund
et al., 1997; Furukawa, Morrow, & Cepko, 1997; Furuk-
awa, Morrow, Li, Davis, & Cepko, 1999). Mutations of
the CRX gene are linked to a number of retinal disorders,
such as cone–rod dystrophy (Swain et al., 1997) and
Leber congenital amaurosis (Swaroop et al., 1999). A
number of cone- and rod-speciﬁc genes have been found
Fig. 4. Veriﬁcation of microarray data by qRT-PCR analysis. RNA samples used for microarray analysis mock (mock) and 100 nM T3 (TH) were
subjected to qRT-PCR to measure the expression levels of the 37 target genes identiﬁed by microarray analysis. The data for all 37 genes can be found in
Table 4. This ﬁgure shows the ampliﬁcation curves of eight genes: GAPDH (used for normalization), LMOD1 (an up-regulated non-retinal gene), 5
up-regulated retinal genes (OPN1LW/MW, CRX, RP1L1, TIMP3 and GNGT2), and 1 down-regulated retinal gene (GNGT1). Each sample contains
three biological replicates and was assayed in duplicate.
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gets we identiﬁed (L/M-opsin gene, ARR3, GCAP1 and
IMPDH1) (Chen et al., 1997; Peng, Ahmad, Ahmad,
Liu, & Chen, 2005; Qian et al., 2005). Chromatin IP
and reporter analysis have shown that CRX can bind to
the promoter and locus control region (LCR) of the L/
M gene locus and activate its transcription (Peng et al.,
2005). However, based on the potency and kinetics ofinduction of L/M-opsin versus CRX, we do not think
CRX is an intermediate factor required for T3 action
on L/M-opsin gene. Instead, it is likely that both CRX
and TRb2 directly bind and activate the L/M-opsin gene.
On the other hand, CRX may mediate the activation of
ARR3 and GCAP1 by T3 based on the relatively slower
kinetics of these genes. The fact that TR and CRX share
a number of common targets and that CRX is also a
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Fig. 5. Dose–response analyses on identiﬁed retinal TH-targets. RNA samples from WERI cells treated for 48 h with either vehicle control (No T3) or
diﬀerent concentrations of T3 (1, 10, 100 nM) were used to perform qRT-PCR to measure the expression level of each gene as indicated in (a)–(d). Fold
inductions was calculated using the ddCt method which show the relative amount of each sample compared to the control (No T3). The data shown are
normalized mean values ± SD of three biological replicates done in duplicate. Statistical analyses were performed using the Student’s t-test and compared
the 1 nM group to the control group (No T3). The * sign indicates p 6 .05, ** sign indicates p 6 .01.
Fig. 6. Time course analyses on identiﬁed retinal TH-targets. RNA samples from WERI cells treated with 5 nM T3 at diﬀerent time points were used to
perform qRT-PCR to measure the expression levels of each gene as indicated in (a)–(d). GAPDH was also measured for normalization. Fold induction
was calculated using the ddCt method which shows the relative amount of samples from each time point compared to the 0 time point. The data shown are
normalized mean values ± SD of three biological replicates done in duplicate. F, fast; M, medium; S, slow.
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cone photoreceptor diﬀerentiation.
TIMP3 is an inhibitor of matrix metalloproteinases
(MMP) and is mutated in Sorsby’s fundus dystrophy
(SFD) (Weber, Vogt, Pruett, Stohr, & Felbor, 1994), an
autosomal dominant retinal degenerative disease. Interest-
ingly, mutant TIMP3 retains its MMP inhibitor activity
and the expression of the TIMP3 gene is increased, rather
than decreased in the eyes from patients with SFD (Fariss,
Apte, Luthert, Bird, & Milam, 1998; Langton, Barker, &
McKie, 1998). Increased expression of TIMP3 has also
been found in other retinal diseases, such as simplex retini-
tis pigmentosa (Jomary, Neal, & Jones, 1995; Jones, Jom-
ary, & Neal, 1994). Our ﬁnding that the expression of
TIMP3 can be signiﬁcantly up-regulated by T3 suggests
that TIMP3 could be involved in thyroid-associated oph-
thalmopathy. It will be interesting to examine the levels
of TIMP3 in patients with hyperthyroidism, such as
Grave’s diseases, to see if such a connection can be
substantiated.
We need to point out that the mechanism of T3 action
on these retinal genes could occur at both transcriptional
and/or post-transcriptional levels as well as directly orindirectly. At this point, we are not able to distinguish
between these possibilities. In silico analysis of the 3 kb
promoter regions of CRX and TIMP3 revealed a few
potential TREs for each gene. However, future experi-
ments are required to determine whether these potential
TREs indeed contribute to the T3-response of these target
genes in vivo.
4.3. Non-retinal genes regulated by thyroid hormone
Thyroid hormone has profound roles in growth, diﬀer-
entiation and metabolic homeostasis. However, after an
extensive search for TH-target genes (reviewed in Kahaly
& Dillmann, 2005; Viguerie & Langin, 2003), the number
of TH-targets identiﬁed is still much lower than expected.
Surprisingly, using the WERI retinoblastoma cell line as a
model system, we identiﬁed a large number of novel tar-
gets of TH. We also veriﬁed, using qRT-PCR, the TH-
regulation of 23 genes that are not currently known to
be retinal genes (deﬁned as non-retinal genes here).
Apparently, even though the retina may not be the pri-
mary tissue for expression of these genes, their activation
by thyroid hormone is still permissive in WERI cells.
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have been previously implicated in thyroid hormone
action. For example, LMOD1, the 2nd most highly
induced gene, was found to be overexpressed in patients
with Grave’s disease, a hyperthyroid disorder (Krom-
minga, Hagel, Arndt, & Schuppert, 1998); DPP4, a dipep-
tidyl peptidase involved in metabolic inactivation of
incretin hormones, has been found to be highly expressed
in thyroid tumors by several gene expression studies
(Huang et al., 2001; Jarzab et al., 2005; Taniguchi
et al., 2005); PYY1 (peptide YY), APOE (apolipoprotein
E) and LIPG (endothelial lipase) are all involved in lipid
metabolism, providing new mechanisms by which TH
could modulate lipid metabolism. We also found three
induced genes, SALL1 (sal-like 1 protein, +6.06-fold),
CRYM (mu crystalline, +2.59-fold), and DELGEF (deaf-
ness locus associated putative guanine nucleotide
exchange factor, +2.61-fold) that are linked to deafness
(Abe et al., 2003; Botzenhart et al., 2005; Uhlmann, Wie-
mann, & Ponstingl, 1999). It is possible that loss of
expression of these genes could be responsible for the
deafness phenotype observed in TRb knock out mice.
In summary, we have identiﬁed a number of novel
TH-target genes using expression microarray analysis
followed by qRT-PCR veriﬁcation. Our ﬁndings may con-
tribute signiﬁcantly to the understanding of the mechanism
of thyroid hormone action during photoreceptor develop-
ment, as well as its involvement in human diseases associ-
ated with alterations of thyroid status.
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